Trump set to nominate Stephen Hahn as FDA commissioner

President Trump is set to nominate Dr. Stephen Hahn, the chief medical executive at MD Anderson Cancer Center, as the next FDA commissioner pending a vetting process, according to two people familiar with the matter. The news was first reported by BioCentury. Trump interviewed Hahn, an oncologist, for the job a month ago. The post has been open since April this year, when former Commissioner Scott Gottlieb stepped down. Since then, Ned Sharpless has served as acting commissioner. Hahn's nomination could be controversial: Several advocacy organizations — and four former commissioners — encouraged the administration to keep Sharpless on permanently. Hahn's record has also been scrutinized: For instance, regulators found this year that MD Anderson had run afoul of federal rules with transgressions that “substantially limit [the] hospital’s capacity to render adequate care.”